Broad-spectrum tinctures grow Medterra’s lineup

3/30/2020

Medterra CBD is moving beyond CBD isolate with its latest product line. Medterra Broad Spectrum Tinctures are bringing whole-hemp formulas to the Irvine, Calif.-based company’s shoppers while upholding its no-THC standard.

"At Medterra, we strive to provide everyone with the highest-quality CBD products on the market and could not be more excited to introduce our line of Broad Spectrum Tinctures," said Medterra CEO Jay Hartenbach. "With growing consumer demand for different cannabinoids, we're excited to offer them exactly that, but without the effects of THC."

The broad-spectrum offerings will be available in 1,000- and 2,000-mg strengths — the former of which retails for $59.99 and the latter of which is priced at $99.99. The products are available in three varieties — unflavored, strawberry mint flavor and citrus flavor.

Among the cannabinoids present in the tinctures are cannabinol, or CBN, and cannabigerol, or CBG. Each bottle contains 30 servings.

Currently, Medterra said it is the most widely distributed CBD company in the world, with its products available through grocery, drug and online retailers at more than 18,000 retail locations.

2026 Retailer Media Network Ratings: Brand, Agency Execs Grade Walmart, Amazon, Kroger & Others

Find out how 21 RMNs fared in this year’s report. Plus, see how CPG organizations are shifting budgets, structuring teams and preparing for what’s next in retail media.

Inside the Race to Win Shoppers in AI-Enabled Marketplace

As AI reshapes how shoppers discover and choose products, brands, platforms and retailers are racing to turn signals, conversations, and intent into measurable growth.

P2PI's 2026 RMN Ratings Report

Members get exclusive access to our full report, featuring performance ratings for more retailer media networks from CPG brand and agency professionals, detailed findings on budget allocation and tactical priorities, and candid feedback from industry leaders.